534 related articles for article (PubMed ID: 24567248)
1. Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa.
Manicklal S; van Niekerk AM; Kroon SM; Hutto C; Novak Z; Pati SK; Chowdhury N; Hsiao NY; Boppana SB
Clin Infect Dis; 2014 May; 58(10):1467-72. PubMed ID: 24567248
[TBL] [Abstract][Full Text] [Related]
2. The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants.
Frederick T; Homans J; Spencer L; Kramer F; Stek A; Operskalski E; Kovacs A
Clin Infect Dis; 2012 Sep; 55(6):877-84. PubMed ID: 22675157
[TBL] [Abstract][Full Text] [Related]
3. Decreased risk of congenital cytomegalovirus infection in children born to HIV-1-infected mothers in the era of highly active antiretroviral therapy.
Guibert G; Warszawski J; Le Chenadec J; Blanche S; Benmebarek Y; Mandelbrot L; Tubiana R; Rouzioux C; Leruez-Ville M;
Clin Infect Dis; 2009 Jun; 48(11):1516-25. PubMed ID: 19388872
[TBL] [Abstract][Full Text] [Related]
4. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Congenital Cytomegalovirus Infection and Associated Risk of In Utero Human Immunodeficiency Virus (HIV) Acquisition in a High-HIV Prevalence Setting, South Africa.
Pathirana J; Groome M; Dorfman J; Kwatra G; Boppana S; Cutland C; Jones S; Madhi SA
Clin Infect Dis; 2019 Oct; 69(10):1789-1796. PubMed ID: 30615106
[TBL] [Abstract][Full Text] [Related]
6. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
7. High rates of congenital cytomegalovirus infection linked with maternal HIV infection among neonatal admissions at a large referral center in sub-Saharan Africa.
Mwaanza N; Chilukutu L; Tembo J; Kabwe M; Musonda K; Kapasa M; Chabala C; Sinyangwe S; Mwaba P; Zumla A; Bates M
Clin Infect Dis; 2014 Mar; 58(5):728-35. PubMed ID: 24265360
[TBL] [Abstract][Full Text] [Related]
8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
9. The interrelated transmission of HIV-1 and cytomegalovirus during gestation and delivery in the offspring of HIV-infected mothers.
Khamduang W; Jourdain G; Sirirungsi W; Layangool P; Kanjanavanit S; Krittigamas P; Pagdi K; Somsamai R; Sirinontakan S; Hinjiranandana T; Ardonk W; Hongsiriwon S; Nanta S; Borkird T; Lallemant M; McIntosh K; Ngo-Giang-Huong N;
J Acquir Immune Defic Syndr; 2011 Oct; 58(2):188-92. PubMed ID: 21792064
[TBL] [Abstract][Full Text] [Related]
10. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
[TBL] [Abstract][Full Text] [Related]
11. Maternal Highly Active Antiretroviral Therapy Reduces Vertical Cytomegalovirus Transmission But Does Not Reduce Breast Milk Cytomegalovirus Levels.
Slyker JA; Richardson B; Chung MH; Atkinson C; Ásbjörnsdóttir KH; Lehman DA; Boeckh M; Emery V; Kiarie J; John-Stewart G
AIDS Res Hum Retroviruses; 2017 Apr; 33(4):332-338. PubMed ID: 27796131
[TBL] [Abstract][Full Text] [Related]
12. Maternal human immunodeficiency virus infection and congenital transmission of cytomegalovirus.
Duryea EL; Sánchez PJ; Sheffield JS; Jackson GL; Wendel GD; McElwee BS; Boney LF; Mallory MM; Owen KE; Stehel EK
Pediatr Infect Dis J; 2010 Oct; 29(10):915-8. PubMed ID: 20431424
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection.
Adachi K; Xu J; Ank B; Watts DH; Mofenson LM; Pilotto JH; Joao E; Santos B; Fonseca R; Kreitchmann R; Pinto J; Mussi-Pinhata MM; Gray G; Theron G; Morgado MG; Bryson YJ; Veloso VG; Klausner JD; Moye J; Nielsen-Saines K;
Clin Infect Dis; 2017 Aug; 65(3):405-413. PubMed ID: 28369278
[TBL] [Abstract][Full Text] [Related]
14. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
15. Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study.
le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Zerbe A; le Roux DM; Kroon M; Myer L
Lancet Child Adolesc Health; 2020 Mar; 4(3):220-231. PubMed ID: 31932246
[TBL] [Abstract][Full Text] [Related]
16. Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics.
Venkatesh KK; Lurie MN; Triche EW; De Bruyn G; Harwell JI; McGarvey ST; Gray GE
Trop Med Int Health; 2010 Nov; 15(11):1364-74. PubMed ID: 20955499
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
18. Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy.
Gantt S; Leister E; Jacobsen DL; Boucoiran I; Huang ML; Jerome KR; Jourdain G; Ngo-Giang-Huong N; Burchett S; Frenkel L
J Med Virol; 2016 Jun; 88(6):1051-8. PubMed ID: 26519647
[TBL] [Abstract][Full Text] [Related]
19. The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009.
Namukwaya Z; Mudiope P; Kekitiinwa A; Musoke P; Matovu J; Kayma S; Salmond W; Bitarakwate E; Mubiru M; Maganda A; Galla M; Byamugisha J; Fowler MG
J Acquir Immune Defic Syndr; 2011 Jan; 56(1):69-75. PubMed ID: 21099692
[TBL] [Abstract][Full Text] [Related]
20. Role of antenatal plasma cytomegalovirus DNA levels on pregnancy outcome and HIV-1 vertical transmission among mothers in the University of Zimbabwe birth cohort study (UZBCS).
Duri K; Chimhuya S; Gomo E; Munjoma PT; Chandiwana P; Yindom LM; Mhandire K; Ziruma A; Mtapuri-Zinyowera S; Mazengera LR; Misselwitz B; Gumbo FZ; Jordi S; Rowland-Jones S;
Virol J; 2021 Jan; 18(1):30. PubMed ID: 33514390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
